Recently, the association between CD28 rs3116496 polymorphism and cancer risk has been widely investigated, such as cervical cancer [19], non-small-cell lung cancer [20], colorectal cancer [21], BC [13], and renal cell carcinoma [22]. The gene discussed is CD28; the disease is breast cancer.